key: cord-0856237-z6124k8e
authors: Caliebe, Reinhard H.; Scior, Thomas; Ammon, Hermann P. T.
title: Binding of boswellic acids to functional proteins of the SARS‐CoV‐2 virus: Bioinformatic studies
date: 2021-08-24
journal: Arch Pharm (Weinheim)
DOI: 10.1002/ardp.202100160
sha: 4f3c77cf8c24b51e849da293f0dc70133e7eea21
doc_id: 856237
cord_uid: z6124k8e

Boswellic acids (BAs) have been shown to possess antiviral activity. Using bioinformatic methods, it was tested whether or not acetyl‐11‐keto‐β‐boswellic acid (AKBA), 11‐keto‐β‐boswellic acid (KBA), β‐boswellic acid (BBA), and the phosphorylated active metabolite of Remdesivir® (RGS‐P3) bind to functional proteins of SARS‐CoV‐2, that is, the replicase polyprotein P0DTD1, the spike glycoprotein P0DTC2, and the nucleoprotein P0DTC9. Using P0DTD1, AKBA and KBA showed micromolar binding affinity to the RNA‐dependent RNA polymerase (RdRp) and to the main proteinase complex M(pro). Phosphorylated BAs even bond in the nanomolar range. Due to their positive and negative charges, BAs and RGS‐P3 bond to corresponding negative and positive areas of the protein. BAs and RGS‐P3 docked in the tunnel‐like cavity of RdRp. BAs also docked into the elongated surface rim of viral M(pro). In both cases, binding occurred with active site amino acids in the lower micromolecular to upper nanomolar range. KBA, BBA, and RGS‐P3 also bond to P0DTC2 and P0DTC9. The binding energies for BAs were in the range of −5.8 to −6.3 kcal/mol. RGS‐P3 and BAs occluded the centrally located pore of the donut‐like protein structure of P0DTC9 and, in the case of P0DTC2, RGS‐P3 and BAs impacted the double‐wing‐like protein structure. The data of this bioinformatics study clearly show that BAs bind to three functional proteins of the SARS‐CoV‐2 virus responsible for adhesion and replication, as does RGS‐P3, a drug on the market to treat this disease. The binding effectiveness of BAs can be increased through phosphate esterification. Whether or not BAs are druggable against the SARS‐CoV‐2 disease remains to be established.

Boswellic acids (BAs)-the pharmacological ingredients of the gum resin of Boswellia species-have been shown to be active in chronic inflammatory diseases with an autoimmune character and inhibit increased expression of proinflammatory cytokines. [1] In addition, antiviral activities have been reported. [2] [3] [4] [5] These observations suggest that BAs may also be active in other types of viruses including SARS-CoV-2.

Molecular modeling and bioinformatics [6, 7] were applied to detect and quantify any potential anti-SARS-CoV-2 activities of three major Boswellia resin constituents, namely, acetyl-11-keto-β- (ii) Blind docking means that the final poses are determined on computational grounds without knowing their experimentally determined binding poses ("blind"). It is generally accepted that, when ligands from crystal structures can be successfully "docked back," then also "blind docking" of hitherto unknown ligands at the same binding site can be considered as trustworthy under the same simulation conditions, that is, unchanged software settings.

(iii) Moreover, advances in structure-activity relationship studies by scaffold-hopping during the last two decades have proven not only similar chemical to similar biological activities by sharing a common molecular binding mechanism to the same target but also congeners based on completely different scaffolds, for example, in the kinome (proteome of the kinases).

For these reasons, our BA screening by AutoDock 4 was limited to the viral interactome, that is, SARS-CoV-2 proteins with known binding sites through experimentally determined ligand complexes (PDB codes: 6M71, [8] 6NUR, [9] 2H2Z, [10] and 6LU7 [11] ).

Taken together, our approach to combine so-called "blinddocking" of BAs (unknown outcome) with so-called "back or selfdocking" of two reference substances (published outcome) constitutes the most valuable asset, that is, we could successfully reproduce the experimentally determined binding modes of both reference substances with their respective targets (RdRp, M pro ). The locations of the binding sites for both target enzymes [9, 11] were identified by superposition techniques. In our first case concerning the target protein for remdesivir, which is the prodrug of RGS-P3, we followed the established protocol set by Shannon and coworkers earlier last

year. [12] In the second case, we studied M pro and applied the Magic Fit module of SPDBV for the 3D alignment with unliganded 2H2Z [10] and liganded 6LU7. [11] Returning to the first case, the binding site became evident only by the user-assisted 3D alignment by Match Maker of Chimera 1.14 [13] of the following four three-dimensional models: (i) SARS-CoV-2 RdRp in complex with cofactors; (ii) SARS-coronavirus NSP12 bound to NSP7 and NSP8 co-factors; (iii) the T7 RNA polymerase alphabeta methylene adenosine triphosphate (ATP) elongation complex; and (iv) the poliovirus polymerase elongation complex (PDB codes: 6M71, 6NUR, 1S76, [14] and 4K4S) [15] as none of the RGS-P3 target structures is available with a binding site-bound drug or inhibitor. In the latter case, the bound ligand is part of the target crystal structure itself (COVID-19 main protease in complex with an experimental inhibitor named N3 [PDB code: 6LU7]). [11] AKBA and KBA are strong binders to both target molecules in the lower micromolecular to upper nanomolar range (see Table 1 ). The The structural similarity of BAs to steroid hormones hints at their capability to enter cell nuclei by the same mechanism as the natural glucocorticoid hormones and drug derivatives, like dexamethasone. [16] In this way, it is safe to state that BAs can enter the cell nuclei and bind to the same site of RGS-P3 binding on the viral RdRp. The expected detrimental effect is a direct consequence of blocking the RNA reading site of the enzyme, a key step in the virus replication after cell infection.

Concerning the viral target M pro , BAs are long enough to fill in a little more than half of the narrow but very extended crevice at This provides opportunities for increment specificity and selectivity of BAs by introducing one or two larger side chains. In cycles of drug design, organic synthesis, and bioassays, novel semisynthetic derivatives could be tested. On the basis of the computed evidence, we draw the conclusion that BAs are recognized by M pro and are amenable to derivatization for drug profiling.

Before docking, the prodrug remdesivir was converted into its active form RGS-P3, which is active at the site of the human RNA polymerase machinery in its triphosphate ester form (RGS-P3).

Structurally, it is similar to ATP (Figure 2 ).

Concerning the spatial subunit arrangement for the multi- is stronger than that of BAs (see Table 1 ). AKBA (light green, purple, gray) has more computed solutions due to its higher degree of conformational freedom than KBA (light blue). Intriguingly, the keto group, which triggers steroid hormone signaling, [16] remained unbounded (four small red balls). It is noteworthy that BBA (without keto group) occupies the same receptor position. 

Administration of therapeutic doses of boswellic extract preparations to humans revealed blood concentrations of KBA in the range of 1.0 to 2.5 µM, but nearly no AKBA could be detected. [17] The binding concentration of RGS, the inactive metabolite of RMSDV, is reported here to be approx. 7.0 kcal/mol. As phos- Using the replicase polyprotein P0DTD1 as the target, the binding energy and the binding concentration of nonphosphorylated and phosphorylated BAs as well as RGS-P3 were tested in RdRp as well as the main protease (see Table 1 ). 

Following the data of Table 1 Table 1 ).

The BA binding site was found to be the same as that of N3 [11] The estimated free energy of binding of N3 is so strong that affinity can be reached in just a 10th of micromolar concentrations (see Table 1 ). 2.4.2 | Binding to P0DTC 9-structure 6VYO Figure 5 shows that RGS-P3 impacts the surface structure of the donut-like protein structure inside the centrally located pore.

The average or mean value (symbol: Ø) reaches the value of −6.5 kcal/mol. KBA occludes the centrally located pore nearly completely. The Ø binding energy is −6.2 kcal/mol, 95% force compared to RGS-P3. BBA occludes the centrally located pore nearly completely, too. The BBA Ø binding energy is −6.3 kcal/mol, 97% force compared to RGS-P3.

The docking study with target 6LVN is shown in Figure 6 . dent on their C-11 keto group as is the case regarding their antiinflammatory activities [1] in direct interaction with the glucocorticoid receptor. [16] In this regard, RGS-P3 spans from one site to the positively charged site of the tunnel-like cavity of RdRp, where its anionic triphosphate rest is anchored by electrostatic attraction. Its cyano group is directed into a negatively charged small pocket at the entrance of the active site of the proteins. In contrast to BAs, RGS-P3 did not bind to the main protease M pro .

Binding energies are strongly related to molar concentrations. The higher the binding energy, the lower the necessary ligand concentration and the stronger the binding. This is evident in The chemical structures of the test substances used for binding studies with virus proteins are shown in Figure 7 . The 3D models of the ligands were obtained from the National Library of Medicine. [ [7] SPDBV, [22] Vega ZZ, [23] Chimera 1.14, [24] AutoDock 4.2 (AD4), [25] AutoDock Tools version 1.5.6, [25] and PyMol version 0.99. [26] 5.3 | Methods 5.3.1 | Settings for the boswellic acid screening by AD4 at the RGS-P3 binding site of RdRp and the N3 binding site of M pro

In view of our experience with a reduced set of functional groups (one ═O; one -OH or -OR sitting on a larger stiff aliphatic ring system), we applied our published docking protocol for BAs. [16] 

Bioinformatic calculations of molecular docking options, energies and positions of ligands to protein structures: For every combination of chemical substance and protein structure, a bioinformatical calculation has been performed using AutoDoc Vina [7] to find the top 20

docking options together with their energies and positions at the appropriate protein structure. The results have been compared to the binding situation of RGS-P3 as the reference ligand.

The authors are grateful to Professor Stefan Laufer, Tuebingen, for valuable scientific advice while preparing the manuscript. Reinhard H.

Caliebe and Thomas Scior equally contributed to computer models.

Open Access funding enabled and organized by Projekt DEAL. 

Weihrauch-Anwendung in der westlichen Medizin

The PyMOL Molecular Graphics System, Version 1.2r3pre

Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: Bioinformatic studies